#LCSM Chat 8/27 8pm ET: Let’s get social… in our health?

by guest host Christina Lizaso The internet has obviously changed a lot of things. One of the most exciting and impactful changes for me has been how it enables patients to find each other and form disease communities. It began with discussion boards; now there are an amazing number of options to suit various interests, styles and comfort levels. The rise of online patient communities has been especially important for those with rare disease and diseases which carry stigma. What is really exciting is to see patient communities go beyond internally supporting… Read More

#LCSM chat 8/13 8pm ET: How can we fight the rising cost of cancer care?

Q A July 23 article in Newsweek titled “The High Cost of Cancer Care: Your Money or Your Life?”  emphasizes a topic of increasing concern:  the escalating costs of new cancer drugs, and the toll this takes on patients and families. A presentation at ASCO 2015 titled “Perspectives in Value” graphically showed the escalating price of cancer drugs in recent years, and how those prices soar off the charts for some new immunotherapies. The presentation also showed how prices of targeted therapy drugs don’t seem to go down as more patients use… Read More

#LCSM Chat 7/30 8pm ET: What’s the Role Today of Whole Brain Radiation for #LungCancer with Brain Metastases?

by H. Jack West, MD Brain metastases are relatively common in lung cancer, seen in about 15% of cases, and the management of them is evolving as technology and our preferences change. For decades, whole brain radiation therapy (WBRT) was the only game in town and did a reasonable job controlling a problem that we couldn’t manage readily any other way – chemotherapy generally doesn’t penetrate well into the brain, and brain surgery is only a feasible option for one or a few brain metastases, not many. But over the past 10-15… Read More